| CAS Number | 66147-29-3 |
| Catalog Number | AG00FDDQ(AGN-PC-0TJKPE) |
| Chemical Name | (S)-4-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)-5-methoxy-5-oxopentanoic acid |
| IUPAC Name | (4S)-4-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid |
| InChI | InChI=1S/C21H24N8O5/c1-29(10-12-9-24-18-16(25-12)17(22)27-21(23)28-18)13-5-3-11(4-6-13)19(32)26-14(20(33)34-2)7-8-15(30)31/h3-6,9,14H,7-8,10H2,1-2H3,(H,26,32)(H,30,31)(H4,22,23,24,27,28)/t14-/m0/s1 |
| InChI Key | JYFDQHNTJJOKAS-AWEZNQCLSA-N |
| MDL Number | MFCD30720350 |
| Molecular Formula | C21H24N8O5 |
| Molecular Weight | 468.4659 |
| SMILES | NC1=NC2=NC=C(N=C2C(=N1)N)CN(C1=CC=C(C(=O)N[C@@H](CCC(=O)O)C(=O)OC)C=C1)C |
| UNII | 5NL2U9S7K1 |
| Synonyms | UNII-5NL2U9S7K1,
5NL2U9S7K1,
66147-29-3,
Methotrexate 1-methyl ester,
1-Methy methotrexate,
Methotrexate alpha-methyl ester,
Methotrexate related compound I,
Methotrexate related compound I [USP],
Methotrexate specified impurity I [EP],
(4S)-4-((4-(((2,4-Diaminopteridin-6-yl)methyl)methylamino)benzoyl)amino)-5-methoxy-5-oxopentanoic acid,
L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, 1-methyl ester,
Methotrexate EP Impurity I,
Methotrexate |A-Methyl Ester,
CS-T-32161,
|
| Complexity | 719 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 468.187g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 34 |
| Hydrogen Bond Acceptor Count | 12 |
| Hydrogen Bond Donor Count | 4 |
| Isotope Atom Count | 0 |
| Molecular Weight | 468.474g/mol |
| Monoisotopic Mass | 468.187g/mol |
| Rotatable Bond Count | 10 |
| Topological Polar Surface Area | 200A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | -1.5 |
GHS Hazard and Precautionary Statements
Certificate of Analysis
Lot Number